Department of Periodontology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Clinic of Periodontics, Gothenburg, Public Dental Service, Region Västra Götaland, Sweden.
Clin Oral Implants Res. 2020 Nov;31(11):1072-1077. doi: 10.1111/clr.13653. Epub 2020 Sep 14.
The aim of the present prospective study was to assess the risk for disease recurrence following surgical therapy of peri-implantitis.
MATERIAL & METHODS: 73 patients (130 implants) treated surgically for peri-implantitis were examined at 1 and 5 years after therapy. The primary outcome was recurrence/progression of disease defined as any of the following events: (a) bone loss >1.0 mm, (b) surgical retreatment, (c) implant removal/loss after year 1. Patient- and implant-related parameters as well as 1-year outcomes were evaluated as potential predictors through multiple logistic regression analysis.
57 implants (44%) displayed recurrence/progression of peri-implantitis during follow-up. Among these, 27 implants were removed. Residual deep probing pocket depth (≥6 mm; odds ratio 7.4; 95% confidence interval 2.8-19.3) and reduced marginal bone level (OR 1.4; 95%CI 1.1-1.7) at 1 year after surgery constituted risk factors for recurrence/progression of disease. Furthermore, implants with modified surfaces were at higher risk than implants with non-modified surfaces (OR 5.1; 95%CI 1.6-16.5).
Implants with (a) residual deep probing pocket depth, (b) reduced marginal bone level, or (c) modified surfaces following surgical therapy of peri-implantitis present with increased risk for recurrence/progression.
本前瞻性研究旨在评估种植体周围炎手术治疗后疾病复发的风险。
对 73 名(130 枚种植体)接受种植体周围炎手术治疗的患者,分别于治疗后 1 年和 5 年进行检查。主要结局为疾病复发/进展,定义为以下任何事件:(a)骨丧失>1.0mm,(b)再次手术治疗,(c)治疗 1 年后种植体脱落/丢失。通过多因素逻辑回归分析评估患者和种植体相关参数以及 1 年治疗结果是否为潜在预测因素。
57 枚种植体(44%)在随访期间出现种植体周围炎复发/进展,其中 27 枚种植体被取出。术后 1 年时仍存在深探诊袋深度(≥6mm;优势比 7.4;95%置信区间 2.8-19.3)和边缘骨水平降低(OR 1.4;95%CI 1.1-1.7)是疾病复发/进展的危险因素。此外,经表面改性的种植体比未经表面改性的种植体发生疾病复发/进展的风险更高(OR 5.1;95%CI 1.6-16.5)。
经种植体周围炎手术治疗后,(a)深探诊袋深度残留,(b)边缘骨水平降低,或(c)表面改性的种植体发生疾病复发/进展的风险增加。